Veeva Systems (NYSE:VEEV – Get Free Report) updated its third quarter 2025 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 1.570-1.580 for the period, compared to the consensus estimate of 1.580. The company issued revenue guidance of $682.0 million-$685.0 million, compared to the consensus revenue estimate of $685.7 million.
Analyst Ratings Changes
VEEV has been the topic of several recent analyst reports. JPMorgan Chase & Co. increased their price objective on shares of Veeva Systems from $203.00 to $208.00 and gave the stock a “neutral” rating in a report on Monday, September 9th. Guggenheim increased their price target on shares of Veeva Systems from $233.00 to $249.00 and gave the stock a “buy” rating in a research note on Tuesday, October 1st. Piper Sandler lifted their price target on shares of Veeva Systems from $230.00 to $280.00 and gave the company an “overweight” rating in a report on Friday, November 8th. StockNews.com upgraded Veeva Systems from a “hold” rating to a “buy” rating in a report on Saturday, November 9th. Finally, Robert W. Baird reduced their target price on Veeva Systems from $251.00 to $245.00 and set an “outperform” rating on the stock in a report on Monday, October 28th. One investment analyst has rated the stock with a sell rating, seven have issued a hold rating and sixteen have issued a buy rating to the company. According to data from MarketBeat.com, Veeva Systems has a consensus rating of “Moderate Buy” and a consensus target price of $237.00.
Read Our Latest Stock Analysis on VEEV
Veeva Systems Price Performance
Veeva Systems (NYSE:VEEV – Get Free Report) last released its quarterly earnings data on Wednesday, August 28th. The technology company reported $1.07 earnings per share for the quarter, beating the consensus estimate of $1.04 by $0.03. The business had revenue of $676.18 million for the quarter, compared to analysts’ expectations of $667.21 million. Veeva Systems had a return on equity of 13.30% and a net margin of 23.91%. Equities research analysts expect that Veeva Systems will post 4.21 earnings per share for the current year.
Insiders Place Their Bets
In other news, SVP Jonathan Faddis sold 2,353 shares of the stock in a transaction dated Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total value of $470,600.00. Following the transaction, the senior vice president now directly owns 9,035 shares of the company’s stock, valued at $1,807,000. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, SVP Jonathan Faddis sold 2,353 shares of Veeva Systems stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $200.00, for a total value of $470,600.00. Following the completion of the sale, the senior vice president now directly owns 9,035 shares in the company, valued at approximately $1,807,000. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, insider Thomas D. Schwenger sold 1,126 shares of the firm’s stock in a transaction on Friday, November 8th. The stock was sold at an average price of $240.01, for a total value of $270,251.26. Following the transaction, the insider now owns 27,013 shares in the company, valued at approximately $6,483,390.13. This trade represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Company insiders own 10.50% of the company’s stock.
Veeva Systems Company Profile
Veeva Systems Inc provides cloud-based software for the life sciences industry. It offers Veeva Commercial Cloud, a suite of software and analytics solutions, such as Veeva customer relationship management (CRM) that enable customer-facing employees at pharmaceutical and biotechnology companies; Veeva Vault PromoMats, an end-to-end content and digital asset management solution; Veeva Vault Medical that provides source of medical content across multiple channels and geographies; Veeva Crossix, an analytics platform for pharmaceutical brands; Veeva OpenData, a customer reference data solution; Veeva Link, a data application that allows link to generate real-time intelligence; and Veeva Compass includes de-identified and longitudinal patient data for the United States.
Featured Articles
- Five stocks we like better than Veeva Systems
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- Top 3 R&D-Driven Stocks Showing Strong Profit and Momentum
- What Are Dividend Contenders? Investing in Dividend Contenders
- Shopify Stock Rally Continues: Why the Growth Story Isn’t Over
- What is the Nasdaq? Complete Overview with History
- Tariff Troubles: 3 Stocks Planning Higher Prices
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.